|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
|
Fig. 2. Activation of Notch signaling on mesoderm, neural plate and neural crest
development. Two-cell stage embryos were injected with NICDGR mRNA in
one blastomere, treated with dexomethasone either directly after the injection
(A,C,E) or at stage 12 (B,D,F), and cultured until stage 25 (A,B) or stage
18-19 (C-F). Subsequently, the expression of distinct markers was analyzed.
The side of the injection is indicated with an arrowhead. (A,B) Immunostaining
of somites with the 12/101 antiserum. Note the expansion of the somite in the
injected side following early activation (A), and the normal morphology after
late activation (B). Following activation at stage 2, 78% of embryos
demonstrated somite expansion (n=70), whereas activation at stage 12
did not produce any expansion of the somites (0%; n=87). (C,D) In
situ hybridization to visualize Sox2 transcripts in the neural plate.
Activation at stage 2 (C) leads to an expansion of the neural plate (65% of
embryos with expanded neural plate; n=83), whereas activation at
stage 12 (D) produces no effect on the neural plate (100% normal;
n=92). (E,F) In situ hybridization to visualize Xslug
transcripts in the cephalic neural crest. Activation at stage 2 (E) produces
an inhibition in the expression of this neural crest marker (58% of
inhibition; n=102), whereas activation at stage 12 (F) produces an
expansion of Xslug expression (expanded in 75% of embryos;
n=152).
|
